Melanie Brignone
Boulogne-billancourt, France
Last Updated: 09/26/2026
Save publications for later
Sign Up
Not sure about your diagnosis?
Check Your Symptoms
Found 24 publications
Optimization of Basic Emollient Therapy for the Management of Xerosis Cutis.
Journal: International journal of dermatology
Published: January 21, 2025
Cost-effectiveness of vortioxetine compared with levomilnacipran and vilazodone in patients with major depressive disorder switching from an initial antidepressant.
Journal: Expert review of pharmacoeconomics & outcomes research
Published: December 14, 2020
Systematic Literature Review and Network Meta-analysis of the Efficacy and Acceptability of Interventions in Actinic Keratoses.
Journal: Acta dermato-venereologica
Published: November 10, 2020
Use of complete clearance for assessing treatment efficacy for 5-fluorouracil interventions in actinic keratoses: how baseline lesion count can impact this outcome.
Journal: Journal of market access & health policy
Published: November 02, 2020
From investigational product to active reference: evolution of oral sumatriptan efficacy versus placebo for the treatment of acute migraine episodes and potential impact in comparative analyses.
Journal: Journal of market access & health policy
Published: August 03, 2018
Comparative evaluation of vortioxetine as a switch therapy in patients with major depressive disorder.
Journal: European neuropsychopharmacology : the journal of the European College of Neuropsychopharmacology
Published: March 24, 2017
Characteristics of patients with depression initiating or switching antidepressant treatment: baseline analyses of the PERFORM cohort study.
Journal: BMC psychiatry
Published: February 15, 2017
A Network Meta-Analysis Comparing Effects of Various Antidepressant Classes on the Digit Symbol Substitution Test (DSST) as a Measure of Cognitive Dysfunction in Patients with Major Depressive Disorder.
Journal: The international journal of neuropsychopharmacology
Published: January 10, 2017
Cost-utility evaluation of vortioxetine in patients with Major Depressive Disorder experiencing inadequate response to alternative antidepressants in the United Kingdom.
Journal: Journal of affective disorders
Published: November 28, 2016
Cost-utility analysis of vortioxetine versus agomelatine, bupropion SR, sertraline and venlafaxine XR after treatment switch in major depressive disorder in Finland.
Journal: Expert review of pharmacoeconomics & outcomes research
Published: September 30, 2016
The effect of vortioxetine on overall patient functioning in patients with major depressive disorder.
Journal: Brain and behavior
Published: March 31, 2016
Cost-effectiveness of vortioxetine versus venlafaxine (extended release) in the treatment of major depressive disorder in South Korea.
Journal: Expert review of pharmacoeconomics & outcomes research
Published: December 08, 2015
Last Updated: 09/26/2026